rs174561与结直肠癌发生发展的相关性研究(2)
[2]陳琼， 刘志才， 程兰平， 等.2003—2007年中国结直肠癌发病与死亡分析[J]. 中国肿瘤， 2012， 21(3)： 179-182.
[3]Schetter AJ， Okayama H， Harris CC， et al. The role of micro RNAs in colorectal cancer[J]. Cancer J， 2012， 18( 3) ： 244-252.
[4]Mohsen Ghanbari；Sanaz Sedaghat；Hans W. J. de Looper； Albert Hofman；Stefan J. Erkeland；Oscar H. Franco；Abbas Dehghan.The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose[J].Obesity.2015，Vol.23(No.2)：495-503.
[5]Yu， Kun1；Cai， Xin-Yi1；Li， Qiang1；Yang， Zhi-Bin1； Xiong， Wei1；Shen， Tao1；Wang， Wei-Ya1；Li， Yun- Feng1 ynsliyunfeng@163.com.OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition. [J]. Biochemical and Biophysical Research Communications.2014.
[6]Lixia Xu1，2；Xiaoxing Li1，3；Muyan Cai3；Jinna Chen4； Xiangchun Li1；William K K Wu1；Wei Kang5；Joanna Tong5；Ka-Fai To5；Xin-Yuan Guan4；Joseph J Y Sung1；Francis K L Chan1；Jun Yu1.Original article： Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer[J]. Gut.2016.
[7]Batlle E， et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435(7045)：1126– 1130. 2. Chiu ST， et al. (2009)
[8]Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis 30(9)： 1475–1486., 百拇医药(曹苏萍 汪维鹏)
[3]Schetter AJ， Okayama H， Harris CC， et al. The role of micro RNAs in colorectal cancer[J]. Cancer J， 2012， 18( 3) ： 244-252.
[4]Mohsen Ghanbari；Sanaz Sedaghat；Hans W. J. de Looper； Albert Hofman；Stefan J. Erkeland；Oscar H. Franco；Abbas Dehghan.The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose[J].Obesity.2015，Vol.23(No.2)：495-503.
[5]Yu， Kun1；Cai， Xin-Yi1；Li， Qiang1；Yang， Zhi-Bin1； Xiong， Wei1；Shen， Tao1；Wang， Wei-Ya1；Li， Yun- Feng1 ynsliyunfeng@163.com.OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition. [J]. Biochemical and Biophysical Research Communications.2014.
[6]Lixia Xu1，2；Xiaoxing Li1，3；Muyan Cai3；Jinna Chen4； Xiangchun Li1；William K K Wu1；Wei Kang5；Joanna Tong5；Ka-Fai To5；Xin-Yuan Guan4；Joseph J Y Sung1；Francis K L Chan1；Jun Yu1.Original article： Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer[J]. Gut.2016.
[7]Batlle E， et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435(7045)：1126– 1130. 2. Chiu ST， et al. (2009)
[8]Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis 30(9)： 1475–1486., 百拇医药(曹苏萍 汪维鹏)
参见：首页 > 医疗版 > 疾病专题 > 消化内科 > 肠道疾病 > 类癌及类癌综合征 > 结、直肠癌